Hyarelief™ Cross- Linked 3.0% 90 mg 3 ml Intra-articular Gel Implant

Hyarelief™ Cross- Linked 3.0% 90 mg 3 ml Intra-articular Gel Implant

Implants, Prosthetics

Information

HyaRelief™ Cross 3.0% is intended for the treatment of symptoms of human joint disorders such as osteoarthritis. HyaRelief™ Cross 3.0% is indicated for viscoelastic replenishment or replacement of synovial fluid in human joints.
Biosan Biyoteknoloji San Ve Dis Tic ASN37.F59Biosan Biotechnology started its R&D studies in Tubitak Marmara Teknokent "R&D and Innovation Center" in 2015 and attaches great importance to its work in the field of medical devices. As Biosan Biotechnology, we continue our product development studies as well as the production of medical devices offered with Hyaluronic Acid-based Pre-filled Injection, whose R&D studies were completed in 2021.